Amphetamobile Develops AMMO RACK App for SciVerse Applications
Researchers to save and organize content for mobile use with document management app
Amsterdam, December 15, 2011 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of the AMMO RACK app on SciVerse Applications. Developed by mobile platform developer Amphetamobile (AMMO), the application enables users to save PDFs of interest in SciVerse for further organization and consumption on their mobile devices.
Using the AMMO RACK app, researchers can store SciVerse article PDFs to an online AMMO RACK cloud storage account and then direct these articles to a complementary document management app for the iPad, iPod or iPhone. Once downloaded to the AMMO RACK app, users can easily sort, assign, read and annotate their documents, whether online or offline.
“SciVerse Applications provides a unique opportunity for us to help researchers pull content deeper into their mobile workflows, providing them with the ability to not only store and view PDFs from SciVerse, but also organize and manage them along with other documents on their mobile devices,” said SiNae Pitts, PhD, CEO of Amphetamobile. “AMMO RACK empowers users to access and consume the content they need more freely and keeps them informed and productive, even when they are offline and on the go.
“We are committed to partnering with organizations that leverage their expertise and technologies in order to develop innovative applications for enhancing the workflow experience of researchers,” said Rafael Sidi, Vice President, Application Marketplace and Developer Network at Elsevier. “Our work with Amphetamobile is an excellent example of the meaningful collaboration that we continuously seek to foster within the scientific community.”
SciVerse Applications and the Developer Network provide opportunities for researchers and librarians to collaborate with developers in creating and promoting new applications that improve research workflows. The Developer Network features a growing community of application developers that gain potential recognition, prestige and revenue through their contributions to SciVerse Applications.
# # #
Amphetamobile (AMMO) is an innovative provider of web and mobile application design, development and consulting. AMMO specializes in mobile content delivery platforms for scholarly publishing, e-learning, and m-health, as well as custom app development. AMMO is led by subject matter expertise in scientific research and a drive for creating refined user interfaces and experiences. AMMO leverages published content through strategic partnerships with internationally recognized publishers and brands to create premium apps with high quality content, intuitive design, and the best possible user experience. Apple’s iTunes staff and app users have identified AMMO apps as noteworthy, valuable, and high-powered. Learn more at www.amphetamobile.com
About the Elsevier SciVerse Suite
The SciVerse ( www.sciverse.com) suite of search and discovery offerings provides the global research community access to a constantly expanding universe of content and solutions which can now be accessed in one platform. The suite currently includes SciVerse ScienceDirect ( www.sciencedirect.com), the world’s largest source of peer-reviewed content containing more than 10 million articles, and SciVerse Scopus (www.scopus.com), an abstract and citation database containing 41 million records, 70% with abstracts and nearly 19,500 titles from 5,000 publishers worldwide. The platform also includes SciVerse Hub beta (www.hub.sciverse.com), which enables researchers to perform a single search across all of the SciVerse content as well as targeted web content with results ranked by relevancy and without duplication. SciVerse Applications (www.applications.sciverse.com) and Developer Network (www.developers.sciverse.com) allow the scientific community to build, find and use applications that enhance the SciVerse research experience.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+1 212 752 8338